Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
37.50
+1.54 (4.28%)
Jul 3, 2026, 4:08 PM HKT

HKG:2335 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Selling, General & Admin
23.4918.81
Research & Development
130.09107.02
Operating Expenses
153.58125.83
Operating Income
-153.58-125.83
Interest Expense
-67-37.65
Interest & Investment Income
2.013.24
Currency Exchange Gain (Loss)
0.480.23
Other Non Operating Income (Expenses)
-9.9-
EBT Excluding Unusual Items
-228-160.02
Gain (Loss) on Sale of Investments
0.872.03
Other Unusual Items
42.221.18
Pretax Income
-184.91-156.81
Income Tax Expense
-0.02
Earnings From Continuing Operations
-184.91-156.83
Minority Interest in Earnings
2.412.2
Net Income
-182.51-154.63
Net Income to Common
-182.51-154.63
Shares Outstanding (Basic)
243234
Shares Outstanding (Diluted)
243234
Shares Change (YoY)
3.71%-
EPS (Basic)
-0.75-0.66
EPS (Diluted)
-0.75-0.66
Free Cash Flow
-138.01-109.04
Free Cash Flow Per Share
-0.57-0.47
EBITDA
-150.12-120.98
D&A For EBITDA
3.464.85
EBIT
-153.58-125.83